(CB) Chubb - Overview

Sector: Financial Services | Industry: Insurance - Property & Casualty | Exchange: NYSE (USA) | Market Cap: 127.245m USD | Total Return: 10% in 12m

Stock Property, Casualty, Reinsurance, Life, Agriculture
Total Rating 72
Safety 76
Buy Signal 0.77
Market Cap: 127,245m
Avg Trading Vol: 546M USD
ATR: 1.86%
Peers RS (IBD): 84.0
Risk 5d forecast
Volatility19.0%
Rel. Tail Risk-6.65%
Reward TTM
Sharpe Ratio0.34
Alpha6.20
Character TTM
Beta0.066
Beta Downside0.388
Drawdowns 3y
Max DD14.35%
CAGR/Max DD1.43
EPS (Earnings per Share) EPS (Earnings per Share) of CB over the last years for every Quarter: "2021-03": 2.52, "2021-06": 3.62, "2021-09": 2.64, "2021-12": 3.81, "2022-03": 3.82, "2022-06": 4.2, "2022-09": 3.17, "2022-12": 4.05, "2023-03": 4.41, "2023-06": 4.92, "2023-09": 4.95, "2023-12": 5.54, "2024-03": 5.41, "2024-06": 5.38, "2024-09": 5.7, "2024-12": 6.02, "2025-03": 3.68, "2025-06": 6.14, "2025-09": 7.49, "2025-12": 7.52,
EPS CAGR: 19.80%
EPS Trend: 75.0%
Last SUE: 1.91
Qual. Beats: 6
Revenue Revenue of CB over the last years for every Quarter: 2021-03: 9975, 2021-06: 9679, 2021-09: 10821, 2021-12: 10480, 2022-03: 9551, 2022-06: 9916, 2022-09: 12082, 2022-12: 11500, 2023-03: 11147, 2023-06: 11828, 2023-09: 13921, 2023-12: 13237, 2024-03: 12905, 2024-06: 13932, 2024-09: 15102, 2024-12: 14180, 2025-03: 13480, 2025-06: 14898, 2025-09: 16139, 2025-12: 15229,
Rev. CAGR: 13.25%
Rev. Trend: 91.0%
Last SUE: 3.66
Qual. Beats: 2
Description: CB Chubb

Chubb Limited (CB) is a global insurer and reinsurer, offering a broad range of products across six segments. The company provides both commercial and personal property & casualty (P&C) insurance, a core offering in the insurance sector.

Its commercial lines include package policies, workers compensation, and professional liability. Personal lines cover homeowners, automobile, and high-value articles. Agricultural insurance is also a significant offering, providing specialized coverage for crops and farms.

Chubbs overseas general insurance and global reinsurance segments extend its reach internationally. Reinsurance is a critical component of the insurance business model, allowing insurers to transfer risk. The company also underwrites life insurance and related protection and savings products.

For a deeper dive into Chubbs financial performance and market position, consider exploring its detailed analytics on ValueRay.

Headlines to Watch Out For
  • Commercial P&C premium growth drives revenue
  • Catastrophe losses impact underwriting profitability
  • Interest rate changes affect investment income
  • Global economic conditions influence insurance demand
  • Regulatory changes alter compliance costs and market access
Piotroski VR‑10 (Strict) 6.0
Net Income: 10.31b TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.11 > 1.0
NWC/Revenue: 28.31% < 20% (prev 24.28%; Δ 4.03% < -1%)
CFO/TA 0.05 > 3% & CFO 13.52b > Net Income 10.31b
Net Debt (19.72b) to EBITDA (14.13b): 1.40 < 3
Current Ratio: 12.28 > 1.5 & < 3
Outstanding Shares: last quarter (396.5m) vs 12m ago -7.30% < -2%
Gross Margin: 33.42% > 18% (prev 0.29%; Δ 3.31k% > 0.5%)
Asset Turnover: 24.17% > 50% (prev 22.76%; Δ 1.41% > 0%)
Interest Coverage Ratio: 18.01 > 6 (EBITDA TTM 14.13b / Interest Expense TTM 764.0m)
Altman Z'' 2.15
A: 0.07 (Total Current Assets 18.41b - Total Current Liabilities 1.50b) / Total Assets 247.83b
B: 0.28 (Retained Earnings 69.95b / Total Assets 247.83b)
C: 0.06 (EBIT TTM 13.76b / Avg Total Assets 247.19b)
D: 0.39 (Book Value of Equity 65.21b / Total Liabilities 168.05b)
Altman-Z'' Score: 2.15 = BBB
Beneish M -3.60
DSRI: 0.43 (Receivables 15.94b/34.49b, Revenue 59.75b/56.12b)
GMI: 0.86 (GM 33.42% / 28.76%)
AQI: 0.98 (AQ_t 0.91 / AQ_t-1 0.93)
SGI: 1.06 (Revenue 59.75b / 56.12b)
TATA: -0.01 (NI 10.31b - CFO 13.52b) / TA 247.83b)
Beneish M-Score: -3.60 (Cap -4..+1) = AAA
What is the price of CB shares? As of April 04, 2026, the stock is trading at USD 325.93 with a total of 1,865,697 shares traded.
Over the past week, the price has changed by +2.90%, over one month by -2.66%, over three months by +4.48% and over the past year by +9.96%.
Is CB a buy, sell or hold? Chubb has received a consensus analysts rating of 3.45. Therefor, it is recommend to hold CB.
  • StrongBuy: 4
  • Buy: 5
  • Hold: 10
  • Sell: 3
  • StrongSell: 0
What are the forecasts/targets for the CB price?
Wallstreet Target Price 338.9 4%
Analysts Target Price 338.9 4%
CB Fundamental Data Overview as of 01 April 2026
P/E Trailing = 12.6743
P/E Forward = 11.7925
P/S = 2.1341
P/B = 1.692
P/EG = 2.8066
Revenue TTM = 59.75b USD
EBIT TTM = 13.76b USD
EBITDA TTM = 14.13b USD
Long Term Debt = 15.73b USD (from longTermDebt, last quarter)
Short Term Debt = 5.03b USD (from shortTermDebt, last quarter)
Debt = 22.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.72b USD (from netDebt column, last quarter)
Enterprise Value = 146.96b USD (127.24b + Debt 22.19b - CCE 2.47b)
Interest Coverage Ratio = 18.01 (Ebit TTM 13.76b / Interest Expense TTM 764.0m)
EV/FCF = 10.87x (Enterprise Value 146.96b / FCF TTM 13.52b)
FCF Yield = 9.20% (FCF TTM 13.52b / Enterprise Value 146.96b)
FCF Margin = 22.62% (FCF TTM 13.52b / Revenue TTM 59.75b)
Net Margin = 17.26% (Net Income TTM 10.31b / Revenue TTM 59.75b)
Gross Margin = 33.42% ((Revenue TTM 59.75b - Cost of Revenue TTM 39.78b) / Revenue TTM)
Gross Margin QoQ = 49.20% (prev 31.18%)
Tobins Q-Ratio = 0.59 (Enterprise Value 146.96b / Total Assets 247.83b)
Interest Expense / Debt = 0.92% (Interest Expense 205.0m / Debt 22.19b)
Taxrate = 15.84% (597.0m / 3.77b)
NOPAT = 11.58b (EBIT 13.76b * (1 - 15.84%))
Current Ratio = 12.28 (Total Current Assets 18.41b / Total Current Liabilities 1.50b)
Debt / Equity = 0.30 (Debt 22.19b / totalStockholderEquity, last quarter 73.76b)
Debt / EBITDA = 1.40 (Net Debt 19.72b / EBITDA 14.13b)
Debt / FCF = 1.46 (Net Debt 19.72b / FCF TTM 13.52b)
Total Stockholder Equity = 70.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.17% (Net Income 10.31b / Total Assets 247.83b)
RoE = 14.69% (Net Income TTM 10.31b / Total Stockholder Equity 70.18b)
RoCE = 16.01% (EBIT 13.76b / Capital Employed (Equity 70.18b + L.T.Debt 15.73b))
RoIC = 13.44% (NOPAT 11.58b / Invested Capital 86.17b)
WACC = 5.40% (E(127.24b)/V(149.43b) * Re(6.21%) + D(22.19b)/V(149.43b) * Rd(0.92%) * (1-Tc(0.16)))
Discount Rate = 6.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -1.74%
[DCF] Terminal Value 86.97% ; FCFF base≈14.58b ; Y1≈15.58b ; Y5≈18.85b
[DCF] Fair Price = 1.37k (EV 556.22b - Net Debt 19.72b = Equity 536.50b / Shares 391.1m; r=6.0% [WACC]; 5y FCF grow 7.60% → 3.0% )
EPS Correlation: 75.02 | EPS CAGR: 19.80% | SUE: 1.91 | # QB: 6
Revenue Correlation: 91.01 | Revenue CAGR: 13.25% | SUE: 3.66 | # QB: 2
EPS next Quarter (2026-06-30): EPS=6.69 | Chg7d=+0.001 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=21
EPS current Year (2026-12-31): EPS=26.82 | Chg7d=+0.004 | Chg30d=-0.016 | Revisions Net=+1 | Growth EPS=+8.2% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=29.17 | Chg7d=+0.003 | Chg30d=+0.217 | Revisions Net=+5 | Growth EPS=+8.8% | Growth Revenue=+4.9%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.0% (Discount Rate 7.9% - Earnings Yield 7.9%)
[Growth] Growth Spread = +5.0% (Analyst 5.0% - Implied 0.0%)
External Resources